Developer docs
API playgroundTry for free, no card

Search company profiles

Hydromer

Full company profile

uuid0003ndr

Namestring
Hydromer
Legal namestring
Hydromer, Inc.
Websiteurl
hydromer.com
Company typeenum
Public
Founded yearint
1980
Descriptiontext

Hydromer, Inc. is a specialty coatings manufacturer founded in 1980 and headquartered in Concord, North Carolina. The company develops and applies hydrophilic, lubricious, and anti-thrombogenic coatings for the medical device industry, and is publicly traded on OTC markets under the ticker HYDI. Hydromer's core platform comprises UV-curable and thermal-curable hydrophilic coating formulations, anti-thrombogenic coatings (including Hygea heparin-based and jHemo PC phosphorylcholine-based chemistries), a portfolio of PTFE liners and tubing, and — since a February 2026 expansion — automated high-speed coating and UV curing equipment. The company sells proprietary coating formulations as products and also delivers services including contract coating, contract R&D, specialized analytical testing, and technology transfer to customer manufacturing facilities.

Hydromer serves medical device manufacturers across cardiovascular, gastroenterology, neurovascular, ophthalmology, peripheral vascular, and urology device categories, with secondary offerings in industrial surface modifiers, anti-fog coatings, hydrogels, and antimicrobial formulations. The company reports it has served more than 1,000 medical device customers worldwide with a 98% repeat customer rate, maintaining a globally mirrored support network with production and service hubs across the Americas and Asia, plus distribution reach into Europe, the Middle East, Africa, and South America. Certifications include ISO 9001:2015 (TUV Rheinland), ISO 13485:2016 (BSI), and FDA facility registration, and Hydromer explicitly positions itself as providing regulatory support for FDA Quality System Regulation (21 CFR Part 820) compliance.

Hydromer earns revenue through a mix of professional services (contract coating, R&D, analytical testing, technology transfer), one-time product sales (coating formulations, PTFE tubing components), hardware sales (automated coating and UV curing equipment), and licensing-style sales of industrial specialty formulations. Go-to-market is sales-led and direct, supplemented by technical content (downloadable product sheets, white papers) and a LinkedIn presence. In October 2025 Hydromer received a strategic investment from jMedtech alongside formation of a new Board of Directors, and in February 2026 the company announced expansion into coating equipment manufacturing — moves intended to broaden the platform beyond coatings chemistry into integrated coatings-plus-equipment offerings.

Short descriptiontext

Hydromer, Inc. is a Concord, NC-based specialty manufacturer of hydrophilic and anti-thrombogenic coatings for medical devices, serving 1,000+ cardiovascular, GI, neurovascular, ophthalmology, peripheral vascular, and urology OEMs with formulations, contract coating, R&D, and automated coating equipment.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersConcord, United States
HQ citystring
Concord
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
hydrophilic coatings, medical device coatings, anti-thrombogenic coatings, coating equipment, contract coating services
Industry2 codes
PRIMARYIMAEAGAB
Industrial & Protective Coatings
SECONDARYIMAIAAAK
Industrial & Commercial Painting/Coatings/Surface Treatment
NAICS code1 code
  • Paint and Coating Manufacturing325510
SIC code2 codes
  • Paints, Varnishes, Lacquers, Enamels & Allied Prods2851
  • Miscellaneous Chemical Products2890
Product category
Medical Device Coatings
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model5 records
1Contract Coating Services
TypeProfessional Services
Description

Provides coating application services for medical device manufacturers on a contract basis, including mass production validation.

hydromer.com
2Coating Products Sales
TypeOne Time License
Description

Sale of proprietary hydrophilic coatings, thromboresistant coatings, and coating equipment to medical device companies.

hydromer.com
3R&D Services
TypeProfessional Services
Description

Customer-driven R&D projects including product evaluation, testing, formulation development, and technology transfer services.

hydromer.com
4Coating Equipment
TypeHardware Sales
Description

Manufacturing and supplying automated high-speed coating and UV curing equipment for medical device manufacturers.

hydromer.com
5Industrial Coatings
TypeOne Time License
Description

Industrial surface modifier products for non-medical applications including marine, automotive, and consumer products.

hydromer.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 7 records shown
1Hygea®
Description

Heparin Antithrombogenic Coating - Heparin-based anti-thrombogenic coating technology

hydromer.com
+6 more records
Core offering1 text field

Hydromer manufactures and sells proprietary hydrophilic coating formulations (UV-curable and thermal-curable) and anti-thrombogenic coatings for the medical device industry, alongside automated coating/curing equipment, PTFE liners and tubing, and friction testing systems. The company also delivers contract coating, R&D, analytical testing, and technology transfer services to medical device OEMs, and offers specialty industrial surface modifiers, hydrogels, and anti-fog coatings for non-medical applications.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 98% repeat customer rate
+1 more record
Product overview1 text field

Hydromer is a platform of hydrophilic coating technologies, equipment, and services for the medical device industry. The core offerings include UV-Curable and Thermal-Curable Hydrophilic Coatings, anti-thrombogenic coatings (Hydromer® Thromboresistant, Hygea® Heparin, and jHemo PC® Phosphorylcholine), and PTFE tubing products. These are complemented by automated coating equipment, friction testing systems, and contract services including R&D, analytical testing, and technology transfer. The company also produces specialty surface modifiers, hydrogels, and industrial coatings such as Brillianz® and Luxere® anti-fog products, and Sea-Slide® testing equipment. The portfolio is delivered as both products and services, combining proprietary formulations with manufacturing equipment and validation support.

Product and service18 records
1UV-Curable Hydrophilic Coatings
CategoryMedical Device Coatings
Description

Advanced hydrophilic coating formulations that cure under UV light, enabling rapid processing for medical device manufacturers. Used on catheters, guidewires, and other invasive medical devices to deliver lubricious, low-friction surfaces.

2Thermal-Curable Hydrophilic Coatings
CategoryMedical Device Coatings
Description

Hydrophilic coating systems that cure via thermal energy, designed for substrates requiring heat-based processing. Used on medical devices for lubricity and improved navigability.

3Hydromer® Thromboresistant Coatings
CategoryAnti-Thrombogenic Coatings
Description

Surface coatings engineered to reduce thrombogenesis (blood clot formation) on medical devices contacting blood, enhancing hemocompatibility for cardiovascular and neurovascular implants and instruments.

4Hygea® Heparin Antithrombogenic Coating
CategoryAnti-Thrombogenic Coatings
Description

Heparin-based coating technology providing antithrombogenic properties for medical devices in contact with blood, developed as a sub-brand within Hydromer's anti-thrombogenic platform.

5jHemo PC® Phosphorylcholine Hemocompatible Coating
CategoryAnti-Thrombogenic Coatings
Description

Phosphorylcholine-based coating that mimics natural cell membrane properties for superior hemocompatibility. Developed in partnership with jMedtech.

6Automated High-Speed Coating and UV Curing Equipment
CategoryCoating Equipment
Description

Manufacturing and supply of automated, high-throughput hydrophilic coating systems and UV curing systems for medical device manufacturers requiring high-volume production.

7Hydrophilic Coating Equipment
CategoryCoating Equipment
Description

Coating application equipment ranging from fully automated high-throughput systems to lower capacity systems for applying hydrophilic coatings.

8Friction Testing Equipment (Sea-Slide®)
CategoryTesting Equipment
Description

Testing equipment and systems used to evaluate lubricity and friction characteristics of coated surfaces, including the Sea-Slide® friction testing system.

9PTFE Liners and Tubing
CategoryMedical Device Components
Description

Polytetrafluoroethylene (PTFE) liner tubing, mini tubing, multi-lumen tubing, and heat-shrink tubing products for medical device applications requiring low friction and chemical resistance.

10Brillianz® UV Stable Anti-Fog Coating
CategoryIndustrial Specialty Coatings
Description

UV-stable anti-fog and condensation control coating for various applications including eyewear and optical devices.

11Luxere® Anti-Fog Coating
CategoryIndustrial Specialty Coatings
Description

Temporary anti-fog coating with antimicrobial properties for various substrates.

12ABRATE-X518™ Industrial Coating
CategoryIndustrial Specialty Coatings
Description

Industrial surface modifier coating for marine and surface modification applications.

13Hydrogels
CategorySpecialty Chemical Products
Description

Polymer-based hydrogel formulations for healthcare, personal care, and industrial applications.

14Surface Modifiers
CategorySpecialty Chemical Products
Description

Customized coating formulations providing special surface properties including friction reduction, protein adhesion resistance, and bio-fouling prevention for marine and industrial applications (e.g., boats, sea planes, surfboards).

15Contract Coating Services
CategoryCoating Services
Description

Outsourced hydrophilic and thromboresistant coating application services for medical device manufacturers, including mass production validation.

16Contract R&D Services
CategoryCoating Services
Description

Research and development services for coating formulation development and device optimization, including product evaluation, testing, formulation development, and technology transfer.

17Specialized Analytical Testing Services
CategoryCoating Services
Description

Testing services for coating performance evaluation including lubricity, thromboresistance, and biocompatibility.

18Technology Transfer Services
CategoryCoating Services
Description

Services to transfer Hydromer's coating technologies and processes to customer manufacturing facilities, enabling in-house coated device production.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Precision Coating
TypeDirect peer
Description

Precision Coating provides coating application services and surface treatment solutions for medical devices and industrial applications, including fluoropolymer and hydrophilic coatings. Comparable to Hydromer's contract coating services business targeting medical device OEMs.

2Lubrizol Life Sciences
TypeBroad incumbent
Description

Lubrizol Life Sciences (part of Berkshire Hathaway) develops specialty polymers and coatings for medical devices, including hydrophilic and lubricious coating chemistries. Comparable as a larger, broader incumbent supplying specialty coating materials to medical device manufacturers.

3Medicoat AG
TypeDirect peer
Description

Medicoat AG provides medical device coating services and biocompatible surface treatments, particularly for orthopedic and cardiovascular implants. Directly comparable to Hydromer's contract coating and R&D service offerings to medical device OEMs.

TypeDirect peer
Description

Harland Medical Systems provides contract coating services, coating equipment, and surface treatment solutions to medical device manufacturers. Comparable to Hydromer in offering both contract services and coating application equipment to the same medical device OEM customer base.

TypeDirect peer
Description

Surmodics is a direct competitor in medical device hydrophilic and thromboresistant coatings, offering proprietary coating chemistries, coating application services, and surface modification technologies to medical device OEMs globally. Highly comparable business model and target customer base to Hydromer.

TypeEmerging player
Description

AST Products develops surface modification and coating technologies for medical devices and industrial applications. Comparable to Hydromer in specialty hydrophilic and lubricious coatings, though smaller in scale and with narrower market presence.

TypeDirect peer
Description

Covalon Technologies develops antimicrobial and advanced wound care coatings with medical-grade surface modification technologies. Comparable to Hydromer in medical coatings focus, including antimicrobial coating offerings that overlap with Hydromer's CarvaTech product line.

TypeDirect peer
Description

Specialty Coating Systems provides Parylene and other conformal coating services and equipment for medical, electronics, and industrial applications. Comparable to Hydromer in offering contract coating services and application equipment, though SCS focuses more on Parylene and electronics.

TypeBroad incumbent
Description

DSM Biomedical, part of dsm-firmenich, is a large materials company supplying biomedical coatings, polymers, and surface modification solutions to medical device manufacturers. Comparable as a broader incumbent in the medical device coatings space, though DSM operates across a much wider portfolio.

10Biocoat
TypeDirect peer
Description

Biocoat specializes in hydrophilic coatings for medical devices, particularly for guidewires, catheters, and similar interventional products. Directly comparable to Hydromer's core UV-curable and thermal-curable hydrophilic coating offerings to medical device manufacturers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Hydromer

Medical Device Coatingshydromer.com

Hydromer, Inc. is a Concord, NC-based specialty manufacturer of hydrophilic and anti-thrombogenic coatings for medical devices, serving 1,000+ cardiovascular, GI, neurovascular, ophthalmology, peripheral vascular, and urology OEMs with formulations, contract coating, R&D, and automated coating equipment.

What Hydromer does

Hydromer, Inc. is a specialty coatings manufacturer founded in 1980 and headquartered in Concord, North Carolina. The company develops and applies hydrophilic, lubricious, and anti-thrombogenic coatings for the medical device industry, and is publicly traded on OTC markets under the ticker HYDI. Hydromer's core platform comprises UV-curable and thermal-curable hydrophilic coating formulations, anti-thrombogenic coatings (including Hygea heparin-based and jHemo PC phosphorylcholine-based chemistries), a portfolio of PTFE liners and tubing, and — since a February 2026 expansion — automated high-speed coating and UV curing equipment. The company sells proprietary coating formulations as products and also delivers services including contract coating, contract R&D, specialized analytical testing, and technology transfer to customer manufacturing facilities.

Hydromer serves medical device manufacturers across cardiovascular, gastroenterology, neurovascular, ophthalmology, peripheral vascular, and urology device categories, with secondary offerings in industrial surface modifiers, anti-fog coatings, hydrogels, and antimicrobial formulations. The company reports it has served more than 1,000 medical device customers worldwide with a 98% repeat customer rate, maintaining a globally mirrored support network with production and service hubs across the Americas and Asia, plus distribution reach into Europe, the Middle East, Africa, and South America. Certifications include ISO 9001:2015 (TUV Rheinland), ISO 13485:2016 (BSI), and FDA facility registration, and Hydromer explicitly positions itself as providing regulatory support for FDA Quality System Regulation (21 CFR Part 820) compliance.

Hydromer earns revenue through a mix of professional services (contract coating, R&D, analytical testing, technology transfer), one-time product sales (coating formulations, PTFE tubing components), hardware sales (automated coating and UV curing equipment), and licensing-style sales of industrial specialty formulations. Go-to-market is sales-led and direct, supplemented by technical content (downloadable product sheets, white papers) and a LinkedIn presence. In October 2025 Hydromer received a strategic investment from jMedtech alongside formation of a new Board of Directors, and in February 2026 the company announced expansion into coating equipment manufacturing — moves intended to broaden the platform beyond coatings chemistry into integrated coatings-plus-equipment offerings.

Hydromer firmographics

Firmographics
Name
Hydromer
Legal name
Hydromer, Inc.
Website
https://hydromer.com
Company type
Public
Founded year
1980
Operating status
Operating
Headcount range
11–50 employees
Short description
Hydromer, Inc. is a Concord, NC-based specialty manufacturer of hydrophilic and anti-thrombogenic coatings for medical devices, serving 1,000+ cardiovascular, GI, neurovascular, ophthalmology, peripheral vascular, and urology OEMs with formulations, contract coating, R&D, and automated coating equipment.
Ownership category
akta.pro rank

Hydromer industry classification

Industry
Product category
Medical Device Coatings
NAICS
Paint and Coating Manufacturing (325510)
SIC
Paints, Varnishes, Lacquers, Enamels & Allied Prods (2851), Miscellaneous Chemical Products (2890)
akta.pro industry
PRIMARYIMAEAGAB
Industrial & Protective Coatings
SECONDARYIMAIAAAK
Industrial & Commercial Painting/Coatings/Surface Treatment

Keywords

  • Hydrophilic coatings
  • Medical device coatings
  • Anti-thrombogenic coatings
  • Coating equipment
  • Contract coating services

Where Hydromer is headquartered

Location

Headquarters

HQ city
Concord
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Hydromer business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. Contract Coating Services: Provides coating application services for medical device manufacturers on a contract basis, including mass production validation.
  2. Coating Products Sales: Sale of proprietary hydrophilic coatings, thromboresistant coatings, and coating equipment to medical device companies.
  3. R&D Services: Customer-driven R&D projects including product evaluation, testing, formulation development, and technology transfer services.
  4. Coating Equipment: Manufacturing and supplying automated high-speed coating and UV curing equipment for medical device manufacturers.
  5. Industrial Coatings: Industrial surface modifier products for non-medical applications including marine, automotive, and consumer products.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Hydromer product offering

Product offering

Core offering

Hydromer manufactures and sells proprietary hydrophilic coating formulations (UV-curable and thermal-curable) and anti-thrombogenic coatings for the medical device industry, alongside automated coating/curing equipment, PTFE liners and tubing, and friction testing systems. The company also delivers contract coating, R&D, analytical testing, and technology transfer services to medical device OEMs, and offers specialty industrial surface modifiers, hydrogels, and anti-fog coatings for non-medical applications.

Product overview

Hydromer is a platform of hydrophilic coating technologies, equipment, and services for the medical device industry. The core offerings include UV-Curable and Thermal-Curable Hydrophilic Coatings, anti-thrombogenic coatings (Hydromer® Thromboresistant, Hygea® Heparin, and jHemo PC® Phosphorylcholine), and PTFE tubing products. These are complemented by automated coating equipment, friction testing systems, and contract services including R&D, analytical testing, and technology transfer. The company also produces specialty surface modifiers, hydrogels, and industrial coatings such as Brillianz® and Luxere® anti-fog products, and Sea-Slide® testing equipment. The portfolio is delivered as both products and services, combining proprietary formulations with manufacturing equipment and validation support.

Differentiator

Problem solved

Functional benefit

Brands

  • Hygea®: Heparin Antithrombogenic Coating - Heparin-based anti-thrombogenic coating technology
  • jHemo PC®
  • Sea-Slide®
  • Brillianz®
  • Luxere®
  • ABRATE-X518™
  • CarvaTech®

Products and services

  • UV-Curable Hydrophilic Coatings Advanced hydrophilic coating formulations that cure under UV light, enabling rapid processing for medical device manufacturers. Used on catheters, guidewires, and other invasive medical devices to deliver lubricious, low-friction surfaces.
  • Thermal-Curable Hydrophilic Coatings Hydrophilic coating systems that cure via thermal energy, designed for substrates requiring heat-based processing. Used on medical devices for lubricity and improved navigability.
  • Hydromer® Thromboresistant Coatings Surface coatings engineered to reduce thrombogenesis (blood clot formation) on medical devices contacting blood, enhancing hemocompatibility for cardiovascular and neurovascular implants and instruments.
  • Hygea® Heparin Antithrombogenic Coating Heparin-based coating technology providing antithrombogenic properties for medical devices in contact with blood, developed as a sub-brand within Hydromer's anti-thrombogenic platform.
  • jHemo PC® Phosphorylcholine Hemocompatible Coating Phosphorylcholine-based coating that mimics natural cell membrane properties for superior hemocompatibility. Developed in partnership with jMedtech.
  • Automated High-Speed Coating and UV Curing Equipment Manufacturing and supply of automated, high-throughput hydrophilic coating systems and UV curing systems for medical device manufacturers requiring high-volume production.
  • Hydrophilic Coating Equipment Coating application equipment ranging from fully automated high-throughput systems to lower capacity systems for applying hydrophilic coatings.
  • Friction Testing Equipment (Sea-Slide®) Testing equipment and systems used to evaluate lubricity and friction characteristics of coated surfaces, including the Sea-Slide® friction testing system.
  • PTFE Liners and Tubing Polytetrafluoroethylene (PTFE) liner tubing, mini tubing, multi-lumen tubing, and heat-shrink tubing products for medical device applications requiring low friction and chemical resistance.
  • Brillianz® UV Stable Anti-Fog Coating UV-stable anti-fog and condensation control coating for various applications including eyewear and optical devices.
  • Luxere® Anti-Fog Coating Temporary anti-fog coating with antimicrobial properties for various substrates.
  • ABRATE-X518™ Industrial Coating Industrial surface modifier coating for marine and surface modification applications.
  • Hydrogels Polymer-based hydrogel formulations for healthcare, personal care, and industrial applications.
  • Surface Modifiers Customized coating formulations providing special surface properties including friction reduction, protein adhesion resistance, and bio-fouling prevention for marine and industrial applications (e.g., boats, sea planes, surfboards).
  • Contract Coating Services Outsourced hydrophilic and thromboresistant coating application services for medical device manufacturers, including mass production validation.
  • Contract R&D Services Research and development services for coating formulation development and device optimization, including product evaluation, testing, formulation development, and technology transfer.
  • Specialized Analytical Testing Services Testing services for coating performance evaluation including lubricity, thromboresistance, and biocompatibility.
  • Technology Transfer Services Services to transfer Hydromer's coating technologies and processes to customer manufacturing facilities, enabling in-house coated device production.

Quantifiable outcome

  • 98% repeat customer rate
  • +1 more outcomes

Companies that use Hydromer

Customer profile

Named customers2 records

Segments7 records

Ideal customer profiles4 records

Hydromer technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature10 records

Hydromer partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Hydromer competitors and assessment

Company assessment

Direct peers

  • Precision Coating: Precision Coating provides coating application services and surface treatment solutions for medical devices and industrial applications, including fluoropolymer and hydrophilic coatings. Comparable to Hydromer's contract coating services business targeting medical device OEMs.
  • Medicoat AG: Medicoat AG provides medical device coating services and biocompatible surface treatments, particularly for orthopedic and cardiovascular implants. Directly comparable to Hydromer's contract coating and R&D service offerings to medical device OEMs.
  • Harland Medical Systems: Harland Medical Systems provides contract coating services, coating equipment, and surface treatment solutions to medical device manufacturers. Comparable to Hydromer in offering both contract services and coating application equipment to the same medical device OEM customer base.
  • Surmodics: Surmodics is a direct competitor in medical device hydrophilic and thromboresistant coatings, offering proprietary coating chemistries, coating application services, and surface modification technologies to medical device OEMs globally. Highly comparable business model and target customer base to Hydromer.
  • Covalon Technologies: Covalon Technologies develops antimicrobial and advanced wound care coatings with medical-grade surface modification technologies. Comparable to Hydromer in medical coatings focus, including antimicrobial coating offerings that overlap with Hydromer's CarvaTech product line.
  • Specialty Coating Systems (SCS): Specialty Coating Systems provides Parylene and other conformal coating services and equipment for medical, electronics, and industrial applications. Comparable to Hydromer in offering contract coating services and application equipment, though SCS focuses more on Parylene and electronics.
  • Biocoat: Biocoat specializes in hydrophilic coatings for medical devices, particularly for guidewires, catheters, and similar interventional products. Directly comparable to Hydromer's core UV-curable and thermal-curable hydrophilic coating offerings to medical device manufacturers.

Broad incumbents

  • Lubrizol Life Sciences: Lubrizol Life Sciences (part of Berkshire Hathaway) develops specialty polymers and coatings for medical devices, including hydrophilic and lubricious coating chemistries. Comparable as a larger, broader incumbent supplying specialty coating materials to medical device manufacturers.
  • DSM Biomedical (dsm-firmenich): DSM Biomedical, part of dsm-firmenich, is a large materials company supplying biomedical coatings, polymers, and surface modification solutions to medical device manufacturers. Comparable as a broader incumbent in the medical device coatings space, though DSM operates across a much wider portfolio.

Emerging players

  • AST Products: AST Products develops surface modification and coating technologies for medical devices and industrial applications. Comparable to Hydromer in specialty hydrophilic and lubricious coatings, though smaller in scale and with narrower market presence.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Hydromer social profiles

Digital presence

Hydromer compliance and trust

Trust signal

Compliance3 records

Hydromer financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Hydromer leadership team

Management profile

Number of profiles

Profiles1 record

Hydromer subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Hydromer funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Hydromer M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hydromer

What does Hydromer do?

Hydromer manufactures and sells proprietary hydrophilic coating formulations (UV-curable and thermal-curable) and anti-thrombogenic coatings for the medical device industry, alongside automated coating/curing equipment, PTFE liners and tubing, and friction testing systems. The company also delivers contract coating, R&D, analytical testing, and technology transfer services to medical device OEMs, and offers specialty industrial surface modifiers, hydrogels, and anti-fog coatings for non-medical applications.

Is Hydromer a public or private company?

Hydromer is a public company. It is classified as public and is currently operating.

When was Hydromer founded?

Hydromer was founded in 1980. It employs 11 to 50 people.

Where is Hydromer based?

Hydromer is headquartered in Concord, United States, in the North America region.

How does Hydromer make money?

Five revenue lines are on record. Contract Coating Services are the primary driver. The others are coating Products Sales, R&D Services, coating Equipment and industrial Coatings.

Who are Hydromer's main competitors?

Direct peers on record are Precision Coating, Medicoat AG, Harland Medical Systems, Surmodics, Covalon Technologies, Specialty Coating Systems (SCS) and Biocoat. Broad incumbents are Lubrizol Life Sciences and DSM Biomedical (dsm-firmenich). AST Products is listed as an emerging player.

Does Hydromer have an API?

No public API is recorded for Hydromer.

What industry is Hydromer in?

Hydromer's product category is Medical Device Coatings. Its primary akta.pro industry code is IMAEAGAB, Industrial & Protective Coatings, with a secondary code of IMAIAAAK, Industrial & Commercial Painting/Coatings/Surface Treatment. Its NAICS code is 325510 and its SIC code is 2851.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
TalkMarketsHydrophilic Coatings Market Trends Shaping Advanced Surface TechnologiesThe global hydrophilic coatings market was valued at USD 15.7 billion in 2025 and is projected to reach USD 24.0 billion by 2033, growing at a CAGR of 5.6%, with North America capturing the largest revenue share of 34.4%. The market is driven by increasing demand for minimally invasive medical procedures, where hydrophilic coatings are applied to catheters, guidewires, and endoscopic devices, as well as growing adoption in optics, electronics, automotive, and industrial manufacturing. Key companies including Surmodics Inc., Hydromer Inc., Biocoat Inc., and others are focusing on technological innovations such as thinner coating layers, sustainable formulations, and multifunctional coating technologies to expand applications and meet stringent regulatory standards.Defense WorldComparing Neo Performance Materials (OTCMKTS:NOPMF) and Hydromer (OTCMKTS:HYDI)This article compares Neo Performance Materials (OTCMKTS:NOPMF) and Hydromer (OTCMKTS:HYDI), two basic materials companies, across eight financial metrics including dividends, risk, institutional ownership, analyst recommendations, earnings, valuation, and profitability. Neo Performance Materials beats Hydromer on five of the eight factors compared. Neo Performance Materials generates $478.79 million in revenue with a -2.09% net margin, while Hydromer has lower revenue but higher earnings per share (-$0.06 vs -$0.26).TodaysmedicaldevelopmentsHydromer expands into manufacturing and supply of automated high-speed coating, UV curing equipmentHydromer, Inc., a provider of hydrophilic, thromboresistant, and antimicrobial coating technologies for over 40 years, announced its expansion into manufacturing and supplying automated high-speed coating and UV curing equipment for medical device manufacturers worldwide. The new integrated platform combines the company's proprietary coatings with high-performance machinery, providing an end-to-end solution that supports compliance with ISO 13485 and FDA Quality System Regulations. According to CEO Michael Torti, the expansion eliminates technical barriers for clients and reduces time to market while maintaining quality and regulatory standards.Market Research & Business IntelligenceBiodegradable Implant Succinic Coatings MarketThe global biodegradable implant succinic coatings market is valued at USD 423.2 million in 2026 and is projected to reach USD 956.8 million by 2036, reflecting a compound annual growth rate of 8.5% during the forecast period. Orthopedic implants dominate the implant type segment with a 35% market share, while osseointegration enhancement leads the application segment with a 32% share. Key players in the market include HiMED, Hydromer, Medicoat AG, CAM Bioceramics B.V., and APS Materials, Inc., with India recording the highest country-level growth rate at 10.6% and Japan the lowest among profiled nations at 6.9%.MarketsandMarketsMedical Coatings Market, Industry Size Forecast, [Latest]MarketsandMarkets projects the global medical coating market to grow from USD 9.98 billion in 2025 to USD 15.81 billion by 2030, driven by rising demand for advanced, infection-resistant medical devices and an aging population. Key players such as Hydromer, DSM-Firmenich, and Surmodics are expanding their portfolios with innovations like PFAS-free and drug-eluting coatings to address biocompatibility and durability challenges. Growth is particularly strong in the Asia-Pacific region due to increased healthcare investments and local manufacturing initiatives.HydromerMedical Coatings Services for StartupsThe article promotes Hydromer, Inc. as a specialized partner for medical device startups, highlighting the critical role of surface modification and hydrophilic coatings in ensuring device safety and performance. It outlines key challenges such as regulatory compliance, material compatibility, and testing, positioning Hydromer's full-service capabilities as a solution to reduce development time and costs. The text details specific coating technologies and services offered by Hydromer to help startups navigate the complex path from R&D to market approval.GlobeNewswireHydromer, Inc. Reports Preliminary Unaudited Financial Results for Third Quarter 2024Hydromer reported Q3 2024 revenue of $788,000, down 21% year-over-year, while net income rose 67% to $72,000. Cost of goods sold fell 28% and operating expenses dropped 24%, reflecting cost management amid legacy program order reductions.GlobeNewswireHydromer, Inc. Announces the Restructuring and Formation of World-Class Research and Development Division to Drive Innovation and New Product DevelopmentHydromer, Inc. announced a new R&D division led by Dr. Yonghua Zhou, adding two Ph.D. chemists and one M.S. chemist. The team aims to develop durable, environmentally friendly coatings for medical and industrial applications. CEO Mike Torti said the developments are expected to open new markets for growth.GlobeNewswireHydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business UpdateHydromer, Inc. reported Q2 2024 revenue of $836,000, down 32% year-over-year, and a net ordinary income loss of $6,700, down 102%. The company signed 12 R&D projects and 6 new customer contracts, and plans to exhibit at MEDICA Germany and Medtec China in autumn 2024.Business InsiderHydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business UpdateHydromer, Inc. reported Q2 2024 revenue of $836,000, down 32% year-over-year, and net income of $30,000, down 97%. The company also signed 12 R&D projects and 6 new customers, and plans to exhibit at MEDICA Germany and Medtec China in autumn 2024.